89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled KN035
(89Zr-KN035) PET Imaging in patients with PD-L1 positive solid tumors.